Navigation Links
Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Council's Chairman of the Board
Date:11/2/2012

WASHINGTON, Nov. 2, 2012 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that John Gargiulo, President & CEO, Daiichi Sankyo, Inc., has been elected Chairman of its Board of Directors for 2012-13. Mr. Gargiulo has served on NPC's Board since 2007, most recently as Vice Chair.

(Photo: http://photos.prnewswire.com/prnh/20121102/DC05271)

"For many years, John has been committed to fostering NPC's growth as a leading health care policy research organization," said NPC President Dan Leonard. "We're looking forward to his leadership as chairman.  He brings a strong track record of accomplishment from Daiichi Sankyo and a keen understanding of the issues facing our industry and actionable ideas for change."

"Now more than ever, we need to demonstrate that pharmaceuticals not only successfully treat and cure disease, but that they can help manage the costs of health care over time.  By managing chronic and preventable diseases with medicines that have proven to work, we can reduce hospitalizations, and most of all, help people lead longer and healthier lives," said Mr. Gargiulo. "As chairman, I'm looking forward to leading NPC as it continues to move forward on issues related to balancing the needs of patients with the population, the value of pharmaceuticals, and the use of real-world evidence."

Mr. Gargiulo has more than 25 years of pharmaceutical industry experience. He has been instrumental in building and shaping the company's U.S. commercial operations, particularly its cardiovascular business, since its inception in 1996. He has touched nearly every aspect of business operations including Marketing, Managed Markets and New Product Planning. In the U.S. Daiichi Sankyo markets therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome and metastatic melanoma.

The NPC Board also elected Jeff Huth, Senior Vice President, Managed Markets, Boehringer Ingelheim Pharmaceuticals, Inc., to serve as its Vice Chair, and Anne Whitaker, President, North America Pharmaceuticals, Sanofi, as Treasurer. Rich Fante, President, U.S. Business & Regional Vice President, Americas, AstraZeneca, is the outgoing chair and will remain active on NPC's Board.

"Under Rich's leadership,  NPC took a leap forward as an organization, becoming a more powerful voice in educating key health care stakeholders about the development and application of comparative effectiveness research and other data important to improving health outcomes," said Mr. Leonard.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.  


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
2. Daiichi Sankyo Completes Enrolment in Hokusai - VTE, investigating once-daily Edoxaban in the Largest Single Phase 3 Study for the Treatment and Prevention of Recurrence of VTE
3. Daiichi Sankyo, Inc. Receives FDA Approval to Package Product at New Facility in Bethlehem, PA
4. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
5. DebMed Selected By Three Leading Healthcare Group Purchasing Organizations To Demonstrate Innovative Patient Safety Solution
6. Mylan Selected as a Leading ARV Supplier to Indias National AIDS Control Organization
7. NIH Director Francis S. Collins, M.D., Ph.D. Selected as 2012 Pro Bono Humanum Honoree by Prix Galien USA
8. Pharmaceutical Industry Veteran Al Altomari Elected To Insmeds Board Of Directors
9. Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors
10. ApolloMed ACO Selected To Participate In A Transformative New Initiative Sponsored by the Centers for Medicare and Medicaid Services
11. Nature Made Selected As "Top Recommended Health Product" By U.S. News & World Report And Pharmacy Times
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
Breaking Medicine News(10 mins):